Psychiatry

New data show adverse childhood experiences can cause personality changes proximal to trauma, rather than developing later in life.

New data show ADHD-specific text message intervention beneficial to patients who may have low rate of stimulant treatment adherence.

While treatment options do not impact 30-day readmissions, they can influence hospital length of stay and costs.

Data show effectiveness of DSRM in treating major depressive disorder with less frequent discontinuations.

More research is needed to fully understand the associations with different types of strabismus

Late life depression is a known risk factor for dementia, impacting 8-16% in the US.

New data show mental health workers experienced lower levels of traumatic stress and peritraumatic distress during COVID-19 pandemic, compared to healthcare workers and general population.

The transition from pediatric care to adult care can be confusing for ADHD patients, often leading to a discontinuation of health care services altogether.

Despite higher risk of adverse effects in patients with opioid use disorder, benzodiazepine does not undo protection benefits of buprenorphine.

In a poster presented at APA, researchers review current clinical practice guidelines for schizophrenia.

New data show significant therapeutic effects of dextraomethadone treatment in MDD patients below the median percentage of life-years from diagnosis.

A new study from APA 2021 finds algorithm use can reduce clinical misdiagnosis of bipolar disorder as other mood disorders, including major depressive disorder.

The rates of both diseases have been increasingly linked in recent years.

Dr. Joshua Morganstein discusses the psychological impacts disasters can have on individuals and how the COVID-19 pandemic might be different than other disasters.

The study presented at the 2021 AAN Meeting follows the complete response letter issued by the FDA to Acadia Pharmaceuticals due to deficiencies in their sNDA.

A new cross-sectional survey assessment shows patients more severe disease report worse survey outcomes on emotional wellbeing and social activity.

New cross-sectional survey data suggest quality-of-life and psychological outcomes may differ in the most common chronic skin disease patient populations.

Dr. Jennifer Payne discusses how the events of the last year has impacted her patients and what needs to happen to improve mental health care in the future.

The odds of suicidal behavior was 49% lower for OUD patients receiving substance use disorder treatment.

Larger and longer clinical trials are needed to further test the treatment as a suitable option to treat depression.

According to objective and subjective measures, children with more severe atopic dermatitis were more likely to report a learning disability.

A new study suggests prescriptions for opioid use disorder did not affect current patient treatment, but new OUD patients experienced lower rates of prescription throughout 2020.

A 12-year study finds risk of suicide to be greater for nurses compared to both physicians and the general US population.

A recent study finds no substantial increase in risk of suicide in the first months of COVID-19, particularly in high-income countries.

Investigators conclude data show diminishing returns in treating mild cases of ADHD, but more research is needed to bridge long-term positives and negatives.